UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature

The Annals of pharmacotherapy, 1999-05, Vol.33 (5), p.623-630

1999

Volltextzugriff (PDF)

Rapid tranquilization with olanzapine in acute psychosis: a case series

The journal of clinical psychiatry, 2001, Vol.62 Suppl 2, p.12

2001

Volltextzugriff (PDF)

A case of Tourette syndrome developing during haloperidol treatment

Canadian journal of psychiatry, 1990-04, Vol.35 (3), p.228-232

1990

Volltextzugriff (PDF)

Effects of placebo washout and dose in a comparison of sertraline and amitriptyline

The journal of clinical psychiatry, 1991-09, Vol.52 (9), p.386

Karagianis, J L

1991

Volltextzugriff (PDF)

Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation

The journal of clinical psychiatry, 2010-04, Vol.71 (4), p.433-441

2010

Volltextzugriff (PDF)

Flushing reaction associated with the interaction of phenelzine and clonazepam

Canadian journal of psychiatry, 1991-06, Vol.36 (5), p.389-389

1991

Volltextzugriff (PDF)

Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder

Journal of clinical psychopharmacology, 2009-12, Vol.29 (6), p.520-528

2009

Volltextzugriff (PDF)

High-dose olanzapine and prolactin levels

The journal of clinical psychiatry, 2003-10, Vol.64 (10), p.1192-1194

2003

Volltextzugriff (PDF)

Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics

The journal of clinical psychiatry, 2005-01, Vol.66 (1), p.137; author reply 138

2005

Volltextzugriff (PDF)

Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up

Current medical research and opinion, 2003, Vol.19 (6), p.473-480

2003

Volltextzugriff (PDF)

A case of Tourette syndrome developing during haloperidol treatment

Canadian journal of psychiatry, 1990-04, Vol.35 (Apr 90), p.228-232

1990

Volltextzugriff (PDF)

Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database

The journal of clinical psychiatry, 2012-06, Vol.73 (6), p.e749-e755

2012

Volltextzugriff (PDF)

Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database

Journal of psychopharmacology (Oxford), 2013-04, Vol.27 (4), p.358-365

2013

Volltextzugriff (PDF)

Battle for the planet of the apps

International journal of clinical practice (Esher), 2014-02, Vol.68 (2), p.141-142

2014

Volltextzugriff (PDF)

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study

Schizophrenia research, 2009-08, Vol.113 (1), p.41-48

2009

Volltextzugriff (PDF)

Pharmaism: a tale of two perspectives

International journal of clinical practice (Esher), 2014-06, Vol.68 (6), p.659-661

2014

Volltextzugriff (PDF)

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

Current medical research and opinion, 2013-11, Vol.29 (11), p.1533-1537

2013

Volltextzugriff (PDF)

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

Schizophrenia research, 2011-12, Vol.133 (1), p.266-266

2011

Volltextzugriff (PDF)

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence

Patient preference and adherence, 2011-01, Vol.5, p.213-222

2011

Volltextzugriff (PDF)

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

International journal of clinical practice (Esher), 2010-10, Vol.64 (11), p.1520-1529

2010

Volltextzugriff (PDF)

Case report: edema related to olanzapine therapy

Canadian family physician, 2006-05, Vol.52 (5), p.620-621

2006

Volltextzugriff (PDF)

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study: Weight change during olanzapine therapy

International journal of clinical practice (Esher), 2010-10, Vol.64 (11), p.1520-1529

2010

Volltextzugriff (PDF)

Re: Neuroleptic Malignant Syndrome Associated with Quetiapine

Canadian journal of psychiatry, 2001-05, Vol.46 (4), p.370-370

2001

Volltextzugriff (PDF)

Short Call Abstracts

Thyroid (New York, N.Y.), 2009-09, Vol.19 (s1), p.S-100-S-116

2009

Volltextzugriff (PDF)

Patient Volume, Human Resource Levels, and Attrition From HIV Treatment Programs in Central Mozambique

Journal of acquired immune deficiency syndromes (1999), 2011-07, Vol.57 (3), p.e33-e39

2011

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(25)
Berichte
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Psychiatry
(12)
Antipsychotic Agents - Adverse Effects
(11)
Biological And Medical Sciences
(10)
Female
(10)
Medical Sciences
(10)
Pharmacology. Drug Treatments
(10)
Adult
(9)
Male
(9)
Antipsychotic Agents - Therapeutic Use
(7)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Middle Aged
(7)
Psychology. Psychoanalysis. Psychiatry
(7)
Schizophrenia
(7)
Antipsychotic Agents - Administration & Dosage
(6)
Neuropharmacology
(6)
Olanzapine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature

Rapid tranquilization with olanzapine in acute psychosis: a case series

A case of Tourette syndrome developing during haloperidol treatment

Effects of placebo washout and dose in a comparison of sertraline and amitriptyline

Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation

Flushing reaction associated with the interaction of phenelzine and clonazepam

Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder

High-dose olanzapine and prolactin levels

Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics

Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up

A case of Tourette syndrome developing during haloperidol treatment

Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database

Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database

Battle for the planet of the apps

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study

Pharmaism: a tale of two perspectives

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

Case report: edema related to olanzapine therapy

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study: Weight change during olanzapine therapy

Re: Neuroleptic Malignant Syndrome Associated with Quetiapine

Short Call Abstracts

Patient Volume, Human Resource Levels, and Attrition From HIV Treatment Programs in Central Mozambique

Suchergebnisse filtern